A nurse is instructing a client who is newly diagnosed with pulmonary tuberculosis (TB) about the use of antitubercular medications. Which of the following information should the nurse include in the teaching.

Choice A rationale Antitubercular medications are not taken for the rest of the client's life. Unlike chronic conditions such as HIV or certain thyroid disorders, tuberculosis is a bacterial infection that can be eradicated with a specific, finite course of antibiotics. Once the prescribed regimen is completed and the infection is cleared, the medication is discontinued. Lifetime therapy would be unnecessary and increase the risk of toxicity. Choice B rationale Family members do not automatically take antitubercular medications unless they are diagnosed with active or latent TB. Instead, they are typically screened using a Mantoux skin test or an interferon-gamma release assay. If the screening is positive, then prophylactic treatment like isoniazid might be started. Medication is not given to others without a clinical indication, as all these drugs have significant side effects. Choice C rationale A standard treatment regimen for tuberculosis usually lasts between 6 to 9 months to ensure all Mycobacterium tuberculosis bacteria are killed. This long duration is necessary because the bacteria grow very slowly and can remain dormant. Shortening the course increases the risk of relapse and the development of drug-resistant strains. Consistency and adherence throughout the entire period are critical for a successful cure. Choice D rationale The Mantoux test, or PPD, will often remain positive for the rest of a person's life once they have been infected with TB, even after successful treatment. The test measures the immune system's memory of the bacteria, not the presence of an active infection. Therefore, using the Mantoux test to determine when to stop medication is incorrect. Treatment success is monitored via sputum cultures.